Quick filters
- First Patient Treated In The Boston Scientific ZERO AF Clinical Trial To Evaluate The Safety And Performance Of The Blazer® Open-Irrigated Temperature Ablation Catheter PR Newswire | Wednesday January 16, 2013 11:30AM
- Boston Scientific To Host And Webcast Investor Day Meeting On February 12, 2013 PR Newswire | Tuesday January 8, 2013 12:00PM
- JenaValve Appoints Raymond W. Cohen as Executive Chairman PR Newswire | Monday January 7, 2013 6:00AM
- Boston Scientific to Participate in 31st Annual J.P. Morgan Healthcare Conference PR Newswire | Thursday December 20, 2012 8:30AM
- Boston Scientific Begins Clinical Trial of Patients Implanted with INGEVITY? Pacing Leads PR Newswire | Monday December 17, 2012 8:30AM
- The Boston Scientific Close the Gap Crossroads Classic Brings A Healthy Heart Message To Basketball Fans PR Newswire | Wednesday December 12, 2012 8:30AM
- Boston Scientific Receives European Regulatory Approval For New Precision Spectra? Spinal Cord Stimulator System PR Newswire | Friday December 7, 2012 3:30AM
- First Patient Enrolled in Boston Scientific Randomized Study of Removable WallFlex® Biliary RX Fully Covered Stent for Patients Suffering From Chronic Pancreatitis PR Newswire | Tuesday December 4, 2012 8:30AM
- First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY? Coronary Stent System Featuring a Bioabsorbable Polymer Coating PR Newswire | Friday November 30, 2012 8:30AM
- Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease PR Newswire | Monday November 19, 2012 9:00AM
- Boston Scientific to Acquire Vessix Vascular PR Newswire | Thursday November 8, 2012 10:16AM
- Boston Scientific to Acquire Vessix Vascular, Inc. PR Newswire | Thursday November 8, 2012 7:45AM
- Improved Device Programming Reduces Inappropriate Therapy and Risk of Death for Implantable Defibrillator Patients PR Newswire | Tuesday November 6, 2012 6:59PM
- Michael F. Mahoney Assumes Role of Chief Executive Officer and President of Boston Scientific PR Newswire | Thursday November 1, 2012 7:00AM
- Boston Scientific Receives CE Mark Approval for the SYNERGY? Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating PR Newswire | Wednesday October 31, 2012 8:00AM
- PROMUS Element? and PROMUS Element? Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy PR Newswire | Wednesday October 24, 2012 8:30AM
- Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami PR Newswire | Tuesday October 23, 2012 8:00AM
- The Boston Scientific Epic? Stent Continues to Demonstrate Positive Clinical Outcomes for Patients with Iliac Artery Disease PR Newswire | Tuesday October 23, 2012 8:00AM
- The Boston Scientific PROMUS Element? Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions PR Newswire | Tuesday October 23, 2012 8:00AM
- Boston Scientific Schedule of Major Presentations at Transcatheter Cardiovascular Therapies 2012 PR Newswire | Thursday October 18, 2012 7:42PM
Live Discussion of BSX on StockTwits